Entrada Therapeutics, Inc.
TRDA
$11.88
-$0.71-5.64%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 295.70M | 326.84M | 354.01M | 382.52M | 420.00M |
| Total Receivables | 2.58M | 3.20M | 3.38M | 4.54M | 5.48M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.32M | 8.22M | 11.75M | 16.13M | 14.56M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 658.00K | -- | -- | -- | -- |
| Total Current Assets | 306.25M | 338.26M | 369.15M | 403.19M | 440.04M |
|
|
|||||
| Total Current Assets | 306.25M | 338.26M | 369.15M | 403.19M | 440.04M |
| Net Property, Plant & Equipment | 67.76M | 70.53M | 75.49M | 79.10M | 82.05M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.36M | 4.11M | 4.15M | 4.19M | 4.23M |
| Total Assets | 377.38M | 412.90M | 448.78M | 486.48M | 526.32M |
|
|
|||||
| Total Accounts Payable | 2.29M | 3.17M | 1.86M | 2.19M | 4.26M |
| Total Accrued Expenses | 16.51M | 14.81M | 11.32M | 6.70M | 12.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.14M | 4.35M | 5.46M | 6.51M | 7.56M |
| Total Finance Division Other Current Liabilities | 1.52M | 1.69M | 1.16M | 3.03M | 15.36M |
| Total Other Current Liabilities | 1.52M | 1.69M | 1.16M | 3.03M | 15.36M |
| Total Current Liabilities | 24.45M | 24.02M | 19.80M | 18.43M | 39.48M |
|
|
|||||
| Total Current Liabilities | 24.45M | 24.02M | 19.80M | 18.43M | 39.48M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 46.79M | 48.05M | 49.28M | 50.49M | 51.65M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 113.00K | 194.00K | 301.00K | 6.51M |
| Total Liabilities | 71.25M | 72.18M | 69.28M | 69.22M | 97.64M |
|
|
|||||
| Common Stock & APIC | 578.58M | 574.03M | 568.90M | 563.52M | 558.07M |
| Retained Earnings | -273.09M | -233.93M | -189.80M | -146.69M | -129.34M |
| Treasury Stock & Other | 652.00K | 621.00K | 400.00K | 437.00K | -43.00K |
| Total Common Equity | 306.13M | 340.72M | 379.51M | 417.26M | 428.68M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 306.13M | 340.72M | 379.51M | 417.26M | 428.68M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 306.13M | 340.72M | 379.51M | 417.26M | 428.68M |
|
|
|||||